Fundraising FoxCelleron Therapeutics Venture Capital
Oxford, GB · 1 known investors
Find your way into Celleron Therapeutics Venture Capital
Sign up to see every warm intro you have to Celleron Therapeutics Venture Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Celleron Therapeutics Venture Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
IngenOx Therapeutics is a clinical-stage biopharmaceutical company developing precision drugs and cancer vaccines for patients with advanced, treatment-resistant cancers that evade the immune system. Based in Oxford, UK, it uses an in-house discovery platform for both small-molecule drug development and vaccine development targeting immunologically cold tumours.
Investors · 1
Frequently asked questions
- What does Celleron Therapeutics Venture Capital do?
- IngenOx Therapeutics is a clinical-stage biopharmaceutical company developing precision drugs and cancer vaccines for patients with advanced, treatment-resistant cancers that evade the immune system. Based in Oxford, UK, it uses an in-house discovery platform for both small-molecule drug development and vaccine development targeting immunologically cold tumours.
- Who are Celleron Therapeutics Venture Capital's investors?
- Celleron Therapeutics Venture Capital's investors include IMM Investment Japan.
- Where is Celleron Therapeutics Venture Capital headquartered?
- Celleron Therapeutics Venture Capital is headquartered in Oxford, GB.